Dr. Kevin Kincaid is on the verge of a major breakthrough. He has developed a biological vector that can introduce new genes into the DNA of unborn children-and all their descendants. He hopes to eradicate a wide variety of genetic defects, but others see more sinister uses for this new technology. Who will control mankind's genetic destiny? The government? The medical establishment? Or an international conspiracy of the rich and powerful? GermLine is a tense and topical thriller from the front lines of tomorrow's most wrenching scientific discoveries.
- Paperback | 421 pages
- 148.6 x 214.1 x 18.5mm | 358.33g
- 17 Nov 2003
- St Martin's Press
- Tor Books
- New York, United States
- 1st mass market ed
"Spellbinding! Just as in Gattaca, the science is valid and not only could happen, but will happen if we as a society do not take steps to prevent it. This book is a must-read for anyone who thinks that our scientific advances in genetics will only be used to treat diseases. An outstanding read."
About Nelson Erlick
Dr. Nelson Erlick is Senior Strategist for the Strategic Scientific Services division of a large, international medical communications firm. He is the senior scientific source for matters involving pharmacoeconomic (decision) analysis, statistics, and meta-analysis. A retired surgeon and award-winning researcher, Dr. Erlick lives in Havertown, Pennsylvania.